Table 1 Baseline characteristics of the total population and stratified into groups according to angiographically verified CAD or not
From: Pro-coagulant activity during exercise testing in patients with coronary artery disease
Overall (n = 106) (%) | CAD (n = 70) | No CAD (n = 36) | P-value | |
|---|---|---|---|---|
Age (years) | 62 ± 10 | 63 ± 10 | 60 ± 10 | 0.132 |
Sex (male) | 62 (58.5) | 47 (67.1) | 15 (41.7) | 0.012 |
Smoking (current/past)(%) | 61 (57.5) | 40 (57.1) | 21 (58.3) | 0.907 |
Diabetes (%) | 19 (17.9) | 15 (21.4) | 5 (11.1) | 0.190 |
Hypertension (%) | 67 (63.2) | 44 (62.9) | 23 (63.9) | 0.917 |
Hyperlipidemia (%) | 84 (79.2) | 59 (84.3) | 25 (69.4) | 0.074 |
BMI (kg/m2) | 27.8 ± 4 | 27.9 ± 3.9 | 27.6 ± 3.8 | 0.726 |
Previous CAD (%) | ||||
1.Previous angina | 31 (29.2) | 27 (38.6) | 4 (11.1) | 0.003 |
2.Previous MI | 14 (13.2) | 12 (17.1) | 2 (5.6) | 0.132 |
3.Previous interv. | 27 (25.5) | 25 (35.7) | 2 (5.6) | 0.001 |
Resting SBP (mmHg) | 133 ± 22 | 133 ± 22 | 133 ± 21 | 0.928 |
Resting DBP (mmHg) | 84 ± 10 | 84 ± 11 | 85 ± 9 | 0.621 |
Resting heart rate (bpm) | 70 ± 13 | 68 ± 12 | 73 ± 13 | 0.050 |
ACE-inhib./ARB | 43 (40.6) | 30 (42.9) | 13 (36.1) | 0.503 |
Betablocker | 45 (42.5) | 35 (50) | 10 (27.8) | 0.028 |
Nitrate | 9 (8.5) | 9 (12.9) | 0 | 0.025 |
Statin | 68 (64.2) | 50 (71.4) | 18 (50) | 0.029 |
Aspirin | 71 (67) | 55 (78.6) | 16 (44.4) | <0.001 |